Assistance Publique Hpitaux De Paris competitive analysis

Latest publications and patents of Assistance Publique Hpitaux De Paris New

Explore the latest publications and patents granted to Assistance Publique Hpitaux De Paris, showcasing their recent innovations and technological advancements.

Last updated on: Sep 23, 2025
Publication NumberPublication DateTitleLegal Status

Get instant update for new patents of Assistance Publique Hpitaux De Paris

Oct 4, 2023Il-15 And Il-15Ralpha Sushi Domain Based On ModulokinesGranted And Under Opposition
Nov 23, 2022Method For Treating Checkpoint Inhibitors Induced Adverse EventsGranted And Under Opposition
Nov 24, 2021Implant And GuideGranted And Under Opposition
Oct 27, 2021Interleukin-2 For Treating Food AllergyRevoked
Oct 6, 2021Il-15 And Il-15Raplha Sushi Domain Based ModulokinesGranted And Under Opposition
Aug 11, 2021Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Peripheral Nervous System Of A SubjectGranted And Under Opposition
May 27, 2020Il-2 Dosage Regimen For Treating Systemic Lupus ErythematosusGranted And Under Opposition
May 6, 2020Methods For Performing Antisense Oligonucleotide-Mediated Exon Skipping In The Retina Of A Subject In Need ThereofGranted And Under Opposition
Aug 1, 2018Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory DisordersGranted And Under Opposition
Jul 11, 2018Il-15 And Il-15Raplha Sushi Domain Based ModulokinesOpposition Rejected

Explore Assistance Publique Hpitaux De Paris's recently opposed patents, revealing key competitive challenges and strategic patent disputes in the industry. Track oppositions filed by competitors to understand technology battlegrounds and assess potential risks.

Last updated on: Sep 25, 2025
Patent NumberGrant DateTitleTotal Oppositions
Oct 4, 2023Il-15 And Il-15Ralpha Sushi Domain Based On Modulokines1
Nov 23, 2022Method For Treating Checkpoint Inhibitors Induced Adverse Events1
Nov 24, 2021Implant And Guide1
Oct 27, 2021Interleukin-2 For Treating Food Allergy1
Oct 6, 2021Il-15 And Il-15Raplha Sushi Domain Based Modulokines2
Aug 11, 2021Methods And Pharmaceutical Compositions For Expressing A Polynucleotide Of Interest In The Peripheral Nervous System Of A Subject1
May 27, 2020Il-2 Dosage Regimen For Treating Systemic Lupus Erythematosus1
May 6, 2020Methods For Performing Antisense Oligonucleotide-Mediated Exon Skipping In The Retina Of A Subject In Need Thereof1
Aug 1, 2018Use Of Low Dose Il-2 For Treating Autoimmune - Related Or Inflammatory Disorders1
Jul 11, 2018Il-15 And Il-15Raplha Sushi Domain Based Modulokines1

Latest PTAB cases involving Assistance Publique Hpitaux De Paris

Discover the latest PTAB cases involving Assistance Publique Hpitaux De Paris, highlighting their recent legal challenges and patent disputes.

Peer Comparison New

IP litigation analysis comparing Assistance Publique Hpitaux De Paris with top 3 competitors. Includes complete PTAB case data and opposition data from 2018 onwards.

Last updated on: Sep 25, 2025
CompanyOppositions FiledOppositions FacedPTAB Cases FiledPTAB Cases FacedStrategy Type
ASSISTANCE PUBLIQUE HPITAUX DE PARIS - 9 - - Non-Active
HGF73 - - - Highly Aggressive
SANOFI5923 - - Highly Aggressive
STRAWMAN329 - - - Highly Aggressive